COVID-19 and the kidney.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33004323.
- Also identified by DOI 10.3949/ccjm.87a.20072.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
COVID-19 is primarily considered a respiratory illness, but the kidney may be one of the targets of SARS-CoV-2 infection, since the virus enters cells through the angiotensin-converting enzyme 2 receptor, which is found in abundance in the kidney. Information on kidney involvement in COVID-19 is limited but is evolving rapidly. This article discusses the pathogenesis of acute kidney injury (AKI) in COVID-19, its optimal management, and the impact of COVID-19 on patients with chronic kidney disease, patients with end-stage kidney disease on dialysis, and kidney transplant recipients.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Cost of Illness
- Kidney Diseases
- Pandemics
- Patient Care Management
- Pneumonia, Viral